ABT — Put-Selling Research

by ThetaLoop Research
← Back to search
Last close: 2026-04-02
Abbott Laboratories
Healthcare · $102.87
6.1
/10
Favorable
How this score works →
Regime
Bearish
vs SMA200
SMA200 Distance
-17.2%
Below trend
Volatility
Normal
Average premiums
Momentum
Turning
Price direction
About Abbott Laboratories
Diversified healthcare: medical devices (FreeStyle Libre CGM is the growth engine), diagnostics, nutritional brands (Ensure, Similac), and emerging-market generics. Dividend King yielding ~2.3% with low beta (~0.74). Steady, predictable earnings produce moderate premiums—less binary event risk than pure pharma or biotech, making it a reliable put-selling underlier.
Health Care Equipment
Market Cap
$178.8B
P/E Ratio
27.6
Dividend
245.00%
Beta
0.78
52-Week Range Current: $102.87
$100.88 $139.06
Earnings
2026-04-16
11 days away
Price Action
Bullish Engulfing
Bullish reversal pattern detected on recent candles
📊 View Full Research Track Record (All Wins AND Losses)
These free tools show market conditions and individual scores.
Our daily research goes deeper — covering option-specific data points, strike analysis, and risk metrics delivered via Telegram.
EXPLORE OUR RESEARCH — 14 DAYS FREE